Background illustration for clinical trials search

Paid Clinical Trials Plano

Discover 1,928 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Asciminib Roll-over Study

for
Chronic Myelogenous Leukemia,
Location: Dallas TX, Houston TX, Milwaukee WI, Ann Arbor MI,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 7 - 70+

Code: NCT04877522

Recruiting

Study of STP938 (Dencatistat) in Advanced Solid Tumours

for
Solid Tumor
Location: Dallas TX, San Antonio TX, St. Petersburg FL
Sponsor: Step Pharma, SAS

Sex: All

Age: 18+

Code: NCT06297525

Phase1, Recruiting

Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer

for
Advanced HR+/HER2- Breast Cancer
Location: Dallas TX, Toronto, New Haven CT
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07604571

Phase1, Recruiting

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer,
Location: Dallas TX, St Louis MO, Nashville TN, Greenville SC,
Sponsor: Janux Therapeutics

Sex: Male

Age: 18+

Code: NCT07545811

Phase1, Recruiting

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

for
TP53 Y220C Mutation, Advanced Solid Tumors
Location: Dallas TX, San Antonio TX, Nashville TN, Denver CO,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 18+

Code: NCT07372625

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: NEOK Bio, Inc.

Sex: All

Age: 18+

Code: NCT07612189

Phase1, Recruiting

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Dallas TX, Toronto, Montreal, Boston MA
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07570979

Phase1, Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

for
Prostate Cancer
Location: Dallas TX, San Antonio TX, Kansas City KS, Metairie LA,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06780670

Phase2, Phase3, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for
Somatostatin Receptor Positive (SSTR+),
Location: Dallas TX, Fayetteville AR, New Orleans LA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase3, Recruiting

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

for
PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer
Location: Dallas TX, Little Rock AR, Peoria IL, Columbus OH,
Sponsor: Whitehawk Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07470853

Phase1, Recruiting

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumor, Melanoma, HNSCC, Sarcoma, Squamous Cell Carcinoma,
Location: Dallas TX, Pittsburgh PA, Fairfax VA, Boston MA
Sponsor: ImmVira Pharma Co. Ltd

Sex: All

Age: 18+

Code: NCT04370587

Phase1, Phase2, Recruiting

Study of ON 123300 in Patients With Advanced Cancer

for
Solid Tumors, Adult
Location: Dallas TX, Greenville SC, Grand Rapids MI
Sponsor: Traws Pharma, Inc.

Sex: All

Age: 18+

Code: NCT04739293

Phase1, Recruiting

A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors

for
Solid Tumor
Location: Dallas TX
Sponsor: Abbisko Therapeutics Co, Ltd

Sex: All

Age: 18+

Code: NCT05244551

Phase1, Recruiting

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05379985

Phase1, Phase2, Recruiting

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Dallas TX, Tyler TX, Ocoee FL, Spokane WA, Seattle WA
Sponsor: Corixa Corporation

Sex: All

Age: 18+

Code: NCT00062907

Phase1, Recruiting

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Dallas TX, Houston TX, Ann Arbor MI, Toronto,
Sponsor: LigaChem Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05941507

Phase1, Phase2, Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Dallas TX, Oklahoma City OK, Austin TX, Houston TX,
Sponsor: Iambic Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06253871

Phase1, Recruiting

Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

for
Carcinoma, Squamous Cell
Location: Dallas TX, Aurora CO, Louisville KY, Columbia SC,
Sponsor: Introgen Therapeutics

Sex: All

Age: 18+

Code: NCT00041613

Phase3, Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Dallas TX, Fredericksburg TX, New Braunfels TX,
Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase3, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Dallas TX, Oklahoma City OK, Houston TX, San Antonio TX,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase2, Phase3, Recruiting